Toggle light / dark theme

However, labeling aging itself as a disease is both misleading and detrimental. Pathologizing a universal process makes it seem toxic. In our youth-obsessed society, ageism already runs rampant in Hollywood, the job market, and even presidential races. And calling aging a disease doesn’t address critical questions about why we age in the first place. Instead of calling aging a disease, scientists should aim to identify and treat the underlying processes that cause aging and age-related cellular deterioration.


Aging is associated with heart disease, Alzheimer’s, diabetes, and cancer, but what’s underlying all that?

When crossing the street, which way do you first turn your head to check for oncoming traffic? This decision depends on the context of where you are. A pedestrian in the United States looks to the left for cars, but one in the United Kingdom looks right. A group of scientists at Columbia’s Zuckerman Institute has been studying how animals use context when making decisions. And now, their latest research findings have tied this ability to an unexpected brain region in mice: an area called the anterior lateral motor cortex, or ALM, previously thought to primarily guide and plan movement.

This discovery, published today in Neuron, lends new insight into the brain’s remarkable ability to make decisions. Flexible decision making is a critical tool for making sense of our surroundings; it allows us to have different reactions to the same information by taking context into account.

“Context-dependent decision-making is a building block of higher cognitive function in humans,” said neuroscientist Michael Shadlen, MD, PhD, the paper’s co-senior author with Richard Axel, MD. “Observing this process in a motor area of the mouse brain, as we did with today’s study, puts us a step closer to understanding cognitive function at the level of brain cells and circuits.”

the photo series by vintner and fletcher illustrates three gradual stages of transhumanism from ‘testing ground’, ‘patient zero’ to ‘humanity 2.0’. at the lowest tier, ‘testing ground’ looks into individuals who have created wearable technology to expand their human abilities, improving everything from concentration to mental health.‘patient zero’ studies those who have taken permanent action to become half human and half robot. in the final chapter, ‘humanity 2.0’, the transhumanist subjects focus on life extension and immortality.

The February edition of Journal Club, hosted by Dr. Oliver Medvedik, took a look at a recent paper that explored using gamma stimulation, accomplished through visual and auditory stimuli, to treat Alzheimer’s disease.